Basics ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.4B Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 4.57% Avg Daily Range (30 D): $0.08 | 2.72% Avg Daily Range (90 D): $0.09 | 3.38% Institutional Daily Volume Avg Daily Volume: 3.29M Avg Daily Volume (30 D): 8.06M Avg Daily Volume (90 D): 7.56M Trade Size Avg Trade Size (Sh.): 203 Avg Trade Size (Sh.) (30 D): 383 Avg Trade Size (Sh.) (90 D): 348 Institutional Trades Total Inst.Trades: 1,130 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $1.97M Avg Inst. Trade (90 D): $1.56M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.94M Avg Closing Trade (30 D): $1.63M Avg Closing Trade (90 D): $1.42M Avg Closing Volume: 351.94K     News Jul 9, 2025 @ 12:30 PM Breaking Through: Systemic Genetic Medicines for H... Source: Prnewswire Aug 23, 2024 @ 8:30 PM HCW Biologics Reports Second Quarter 2024 Financia... Source: N/A Jun 26, 2024 @ 1:41 PM ImmunityBio (IBRX) Gains 17% in the Past Week: Her... Source: Zacks Equity Research Mar 20, 2024 @ 3:41 PM Sportradar Group Posts Upbeat Earnings, Joins King... Source: Avi Kapoor Feb 26, 2024 @ 6:57 PM Why Freshpet Shares Are Trading Higher By Around 1... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.15 $-.12 $-.2 Diluted EPS $-.15 $-.14 $-.2 Revenue $ 16.52M $ 6.11M $ 1.05M Gross Profit $ 16.46M $ $ Net Income / Loss $ -129.67M $ -85.75M $ -134.58M Operating Income / Loss $ -64.43M $ -80.25M $ -99.33M Cost of Revenue $ .06M $ M $ M Net Cash Flow $ -82.76M $ -18.15M $ -2.94M PE Ratio